Concepedia

Mark Goldammer

MG

Statistics

Publications

4

Citations

324

H-Index

4

Active since

2003

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Humboldt-Universität zu Berlin

Mark Goldammer is an author at Charité - Universitätsmedizin Berlin specializing in medicine, pharmacokinetics, and pharmacology.

Publications per year

2003–2007

4

Publications

4

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

Julia Kirchheiner, C HEESCH, Steffen Bauer et al. · Clinical Pharmacology & Therapeutics · 2004 · 126 citations

, , +16

<i>MDR1</i> haplotypes derived from exons 21 and 26 do not affect the steady‐state pharmacokinetics of tacrolimus in renal transplant patients

Ingrid Mai, Elke S. Perloff, Steffen Bauer et al. · British Journal of Clinical Pharmacology · 2004 · 77 citations · Full text

, , +17

<i>MDR1</i> Haplotypes Do Not Affect the Steady‐State Pharmacokinetics of Cyclosporine in Renal Transplant Patients

Ingrid Mai, Elke Störmer, Mark Goldammer et al. · The Journal of Clinical Pharmacology · 2003 · 64 citations

, , +17

Vitamin D receptor haplotypes protect against development of colorectal cancer

Jana Flügge, Solveigh Krusekopf, Mark Goldammer et al. · European Journal of Clinical Pharmacology · 2007 · 57 citations

, , +14

1–4 of 4